Malignant neoplasm of undescended left testis
ICD-10 C62.02 is a billable code used to indicate a diagnosis of malignant neoplasm of undescended left testis.
C62.02 refers to a malignant neoplasm located in the left testis that has not descended into the scrotum, a condition known as cryptorchidism. This neoplasm can arise from germ cells or non-germ cell tissues and is more prevalent in males with a history of undescended testis. The risk of developing testicular cancer is significantly higher in individuals with cryptorchidism, particularly if the testis remains undescended beyond infancy. Diagnosis typically involves imaging studies such as ultrasound or MRI, and definitive diagnosis is made through histopathological examination following surgical intervention. Treatment often includes orchiectomy, and depending on the staging, may involve chemotherapy or radiation therapy. The staging of testicular cancer is crucial for determining prognosis and treatment options, with the TNM classification system being commonly used. Fertility considerations are paramount, as the presence of an undescended testis can affect spermatogenesis and overall fertility, necessitating discussions regarding sperm banking prior to treatment.
Detailed history of the patient's testicular descent, imaging results, and treatment plans.
Management of testicular masses, fertility preservation discussions, and post-operative follow-ups.
Urologists must ensure clear documentation of the neoplasm's characteristics and any associated fertility issues.
Staging information, treatment plans, and follow-up care details.
Chemotherapy administration, radiation therapy planning, and monitoring for recurrence.
Oncologists should document the histological type of the neoplasm and any genetic counseling provided.
Used when performing surgical removal of the undescended testis due to malignancy.
Operative report detailing the procedure and findings.
Urologists must document the reason for surgery and any findings related to malignancy.
Undescended testis is a significant risk factor for developing testicular cancer, particularly if not corrected early in life. Regular monitoring and timely intervention are crucial.
